{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T11:14:50Z","timestamp":1783509290567,"version":"3.55.0"},"reference-count":93,"publisher":"MDPI AG","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:p>Onychomycosis is the most common nail disorder, with a global prevalence of approximately 5.5%. It is difficult to cure on both short-term and long-term bases. The most common treatments include the use of oral or topical antifungals. Recurrent infections are common, and the use of systemic oral antifungals raises concerns of hepatotoxicity and drug-drug interactions, particularly in patients with polypharmacy. A number of device-based treatments have been developed for onychomycosis treatment, to either directly treat fungal infection or act as adjuvants to increase the efficacy of topical and oral agents. These device-based treatments have been increasing in popularity over the past several years, and include photodynamic therapy, iontophoresis, plasma, microwaves, ultrasound, nail drilling, and lasers. Some, such as photodynamic therapy, provide more direct treatment, whereas others, such as ultrasound and nail drilling, aid the uptake of traditional antifungals. We conducted a systematic literature search investigating the efficacy of these device-based treatment methods. From an initial result of 841 studies, 26 were deemed relevant to the use of device-based treatments of onychomycosis. This review examines these methods and provides insight into the state of clinical research for each. Many device-based treatments show promising results, but require more research to assess their true impact on onychomycosis.<\/jats:p>","DOI":"10.7547\/21-240","type":"journal-article","created":{"date-parts":[[2023,3,9]],"date-time":"2023-03-09T19:53:22Z","timestamp":1678391602000},"source":"Crossref","is-referenced-by-count":5,"title":["How Effective Are Devices in the Management of Onychomycosis?: A Systematic Review"],"prefix":"10.3390","volume":"113","author":[{"given":"Aditya K.","family":"Gupta","sequence":"first","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna C.","family":"Hall","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron J.","family":"Simkovich","sequence":"additional","affiliation":[{"name":"Mediprobe Research Inc, London, Ontario, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"B1","series-title":"Dermatophytes and Dermatophytoses","first-page":"41","article-title":"\u201cOnychomycosis in the Twenty-First Century: An Update on Epidemiology and Diagnosis,\u201d","author":"Gupta AK","year":"2021","unstructured":"Gupta AK, Venkataraman M, Quinlan EM: \u201cOnychomycosis in the Twenty-First Century: An Update on Epidemiology and Diagnosis,\u201d in Dermatophytes and Dermatophytoses, edited by JP Bouchara, P Nenoff, AK Gupta, V Chaturvedi, p 41, Springer International Publishing, Cham, Switzerland, 2021."},{"key":"B2","series-title":"J Eur Acad Dermatol Venereol","first-page":"1972","article-title":"Onychomycosis: a review","volume":"34","author":"Gupta AK","year":"2020","unstructured":"Gupta AK, Stec N, Summerbell RC, : Onychomycosis: a review. J Eur Acad Dermatol Venereol 34: 1972, 2020.32239567"},{"key":"B3","series-title":"Br J Dermatol","first-page":"287","article-title":"Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis","volume":"182","author":"Gupta AK","year":"2020","unstructured":"Gupta AK, Foley KA, Mays RR, : Monotherapy for toenail onychomycosis: a systematic review and network meta-analysis. Br J Dermatol 182: 287, 2020.31120134"},{"key":"B4","series-title":"J Eur Acad Dermatol Venereol","first-page":"1111","article-title":"A critical review of improvement rates for laser therapy used to treat toenail onychomycosis","volume":"31","author":"Gupta AK","year":"2017","unstructured":"Gupta AK, Versteeg SG: A critical review of improvement rates for laser therapy used to treat toenail onychomycosis. J Eur Acad Dermatol Venereol 31: 1111, 2017.28294418"},{"key":"B5","series-title":"J Dermatol Treat","first-page":"376","article-title":"A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis","volume":"26","author":"Gupta AK","year":"2015","unstructured":"Gupta AK, Paquet M: A retrospective chart review of the clinical efficacy of Nd:YAG 1064-nm laser for toenail onychomycosis. J Dermatol Treat 26: 376, 2015."},{"key":"B6","series-title":"J Am Acad Dermatol","first-page":"95","article-title":"Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: a randomized, multicenter, double-blind, vehicle-controlled phase 3 study","volume":"85","author":"Gupta AK","year":"2021","unstructured":"Gupta AK, Surprenant MS, Kempers SE, : Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: a randomized, multicenter, double-blind, vehicle-controlled phase 3 study. J Am Acad Dermatol 85: 95, 2021.32585278"},{"key":"B7","series-title":"JAPMA","first-page":"20","article-title":"Efficacy of lasers for the management of dermatophyte toenail onychomycosis","volume":"112","author":"Gupta AK","year":"2022","unstructured":"Gupta AK, Venkataraman M, Quinlan EM: Efficacy of lasers for the management of dermatophyte toenail onychomycosis. JAPMA 112: 20, 2022."},{"key":"B8","series-title":"Expert Opin Emerg Drugs","first-page":"213","article-title":"Emerging drugs for the treatment of onychomycosis","volume":"24","author":"Gupta AK","year":"2019","unstructured":"Gupta AK, Stec N: Emerging drugs for the treatment of onychomycosis. Expert Opin Emerg Drugs 24: 213, 2019.31652088"},{"key":"B9","series-title":"J Dermatol Treat","first-page":"783","article-title":"Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration","volume":"32","author":"Wang Y","year":"2019","unstructured":"Wang Y, Lipner SR: Retrospective analysis of adverse events with systemic onychomycosis medications reported to the United States Food and Drug Administration. J Dermatol Treat 32: 783, 2019."},{"key":"B10","series-title":"Curr Drug Res Rev","first-page":"25","article-title":"Onychomycosis: current understanding and strategies for enhancing drug delivery into human nail tissue","volume":"13","author":"Aslam R","year":"2021","unstructured":"Aslam R, Hussain T, Yousaf AM, : Onychomycosis: current understanding and strategies for enhancing drug delivery into human nail tissue. Curr Drug Res Rev 13: 25, 2021.32735534"},{"key":"B11","series-title":"Am J Clin Dermatol","first-page":"149","article-title":"The growing problem of antifungal resistance in onychomycosis and other superficial mycoses","volume":"22","author":"Gupta AK","year":"2021","unstructured":"Gupta AK, Renaud HJ, Quinlan EM, : The growing problem of antifungal resistance in onychomycosis and other superficial mycoses. Am J Clin Dermatol 22: 149, 2021.33354740"},{"key":"B12","series-title":"Skin Appendage Disord","first-page":"351","article-title":"A paradigm shift in the treatment and management of onychomycosis","volume":"7","author":"Gupta AK","year":"2021","unstructured":"Gupta AK, Venkataraman M, Renaud HJ, : A paradigm shift in the treatment and management of onychomycosis. Skin Appendage Disord 7: 351, 2021.34604322"},{"key":"B13","series-title":"Photodiagnosis Photodyn Ther","first-page":"102169","article-title":"Photodynamic therapy: a treatment option for terbinafine resistant Trichophyton species","volume":"33","author":"Shen JJ","year":"2021","unstructured":"Shen JJ, Arendrup MC, Jemec GBE, : Photodynamic therapy: a treatment option for terbinafine resistant Trichophyton species. Photodiagnosis Photodyn Ther 33: 102169, 2021.33497815"},{"key":"B14","series-title":"J Am Acad Dermatol","first-page":"853","article-title":"Onychomycosis: treatment and prevention of recurrence","volume":"80","author":"Lipner SR","year":"2019","unstructured":"Lipner SR, Scher RK: Onychomycosis: treatment and prevention of recurrence. J Am Acad Dermatol 80: 853, 2019.29959962"},{"key":"B15","series-title":"Expert Opin Drug Saf","first-page":"1395","article-title":"Safety of current therapies for onychomycosis","volume":"19","author":"Ricardo JW","year":"2020","unstructured":"Ricardo JW, Lipner SR: Safety of current therapies for onychomycosis. Expert Opin Drug Saf 19: 1395, 2020.32990062"},{"key":"B16","article-title":"Medical devices and clinical trial design for the treatment or improvement in the appearance of fungally-infected nails","unstructured":"US Food and Drug Administration: Medical devices and clinical trial design for the treatment or improvement in the appearance of fungally-infected nails. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/medical-devices-and-clinical-trial-design-treatment-or-improvement-appearance-fungally-infected. Accessed November 17, 2021."},{"key":"B17","series-title":"BMJ","first-page":"n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, : The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372: n71, 2021.33782057"},{"key":"B18","series-title":"Actas Dermosifiliograf","first-page":"795","article-title":"Usefulness of photodynamic therapy in the management of onychomycosis","volume":"106","author":"Robres P","year":"2015","unstructured":"Robres P, Aspiroz C, Rezusta A, : Usefulness of photodynamic therapy in the management of onychomycosis. Actas Dermosifiliograf 106: 795, 2015."},{"key":"B19","series-title":"J Drug Deliv Sci Technol","first-page":"101774","article-title":"Onychomycosis: novel strategies for treatment","volume":"57","author":"Aggarwal R","year":"2020","unstructured":"Aggarwal R, Targhotra M, Sahoo PK, : Onychomycosis: novel strategies for treatment. J Drug Deliv Sci Technol 57: 101774, 2020."},{"key":"B20","series-title":"Cochrane Database Syst Rev","first-page":"CD012093","article-title":"Topical and device-based treatments for fungal infections of the toenails","volume":"1","author":"Foley K","year":"2020","unstructured":"Foley K, Gupta AK, Versteeg S, : Topical and device-based treatments for fungal infections of the toenails. Cochrane Database Syst Rev 1: CD012093, 2020.31978269"},{"key":"B21","series-title":"Recent Pat Drug Deliv Formul","first-page":"203","article-title":"Recent patents on permeation enhancers for drug delivery through nails","volume":"13","author":"Kreutz T","year":"2019","unstructured":"Kreutz T, de Matos SP, Koester LS: Recent patents on permeation enhancers for drug delivery through nails. Recent Pat Drug Deliv Formul 13: 203, 2019.31663846"},{"key":"B22","series-title":"J Eur Acad Dermatol Venereol","first-page":"936","article-title":"Laser therapies for onychomycosis\u2014critical evaluation of methods and effectiveness","volume":"30","author":"Francuzik W","year":"2016","unstructured":"Francuzik W, Fritz K, Salavastru C: Laser therapies for onychomycosis\u2014critical evaluation of methods and effectiveness. J Eur Acad Dermatol Venereol 30: 936, 2016.26953542"},{"key":"B23","series-title":"Med Mycol J","first-page":"J45","article-title":"Laser therapies for onychomycosis in Japan","volume":"59","author":"Kimura U","year":"2018","unstructured":"Kimura U, Suga Y: Laser therapies for onychomycosis in Japan. Med Mycol J 59: J45, 2018.30175813"},{"key":"B24","series-title":"J Cutan Med Surg","first-page":"525","article-title":"Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment","volume":"21","author":"Gupta AK","year":"2017","unstructured":"Gupta AK, Versteeg SG, Shear NH: Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg 21: 525, 2017.28639462"},{"key":"B25","series-title":"J Mycol Med","first-page":"100949","article-title":"Treatment and management strategies of onychomycosis","volume":"30","author":"Aggarwal R","year":"2020","unstructured":"Aggarwal R, Targhotra M, Kumar B, : Treatment and management strategies of onychomycosis. J Mycol Med 30: 100949, 2020.32234349"},{"key":"B26","series-title":"AAPS J","first-page":"25","article-title":"Iontophoresis to overcome the challenge of nail permeation: considerations and optimizations for successful ungual drug delivery","volume":"23","author":"Chen K","year":"2021","unstructured":"Chen K, Puri V, Michniak-Kohn B: Iontophoresis to overcome the challenge of nail permeation: considerations and optimizations for successful ungual drug delivery. AAPS J 23: 25, 2021.33439400"},{"key":"B27","series-title":"Am Fam Physician","first-page":"359","article-title":"Onychomycosis: rapid evidence review","volume":"104","author":"Frazier WT","year":"2021","unstructured":"Frazier WT, Santiago-Delgado ZM, Stupka KC II: Onychomycosis: rapid evidence review. Am Fam Physician 104: 359, 2021.34652111"},{"key":"B28","series-title":"F1000Res","article-title":"Recent advances in therapies for onychomycosis and its management","volume":"8","author":"Gupta AK","year":"2019","unstructured":"Gupta AK, Stec N: Recent advances in therapies for onychomycosis and its management. F1000Res 8: F1000 Faculty Rev-968, 2019.31297182"},{"key":"B29","series-title":"Medicine (Baltimore)","first-page":"e17948","article-title":"Laser treatment for onychomycosis: a systematic review and meta-analysis","volume":"98","author":"Ma W","year":"2019","unstructured":"Ma W, Si C, Kasyanju Carrero LM, : Laser treatment for onychomycosis: a systematic review and meta-analysis. Medicine (Baltimore) 98: e17948, 2019.31770202"},{"key":"B30","series-title":"J Wound Ostomy Continence Nurs","first-page":"333","article-title":"Onychomycosis: diagnosis, treatment, and prevention","volume":"46","author":"Beuscher TL","year":"2019","unstructured":"Beuscher TL, Kelechi TJ: Onychomycosis: diagnosis, treatment, and prevention. J Wound Ostomy Continence Nurs 46: 333, 2019.31274864"},{"key":"B31","series-title":"Dermatol Ther","first-page":"e12855","article-title":"New therapeutic options in the management of superficial fungal diseases","volume":"33","author":"Demirseren DD","year":"2020","unstructured":"Demirseren DD: New therapeutic options in the management of superficial fungal diseases. Dermatol Ther 33: e12855, 2020.30748068"},{"key":"B32","series-title":"Nat Med","first-page":"794","article-title":"Companies go toe to toe, as topical treatments for nail fungus bloom","volume":"19","author":"Willyard C","year":"2013","unstructured":"Willyard C: Companies go toe to toe, as topical treatments for nail fungus bloom. Nat Med 19: 794, 2013."},{"key":"B33","series-title":"Front Microbiol","first-page":"120","article-title":"Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform","volume":"3","author":"Dai T","year":"2012","unstructured":"Dai T, Fuchs BB, Coleman JJ, : Concepts and principles of photodynamic therapy as an alternative antifungal discovery platform. Front Microbiol 3: 120, 2012.22514547"},{"key":"B34","series-title":"Front Microbiol","first-page":"202","article-title":"Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections","volume":"6","author":"Baltazar LM","year":"2015","unstructured":"Baltazar LM, Ray A, Santos DA, : Antimicrobial photodynamic therapy: an effective alternative approach to control fungal infections. Front Microbiol 6: 202, 2015.25821448"},{"key":"B35","series-title":"Clin Endosc","first-page":"24","article-title":"Photodynamic therapy (PDT): PDT mechanisms","volume":"46","author":"Allison RR","year":"2013","unstructured":"Allison RR, Moghissi K: Photodynamic therapy (PDT): PDT mechanisms. Clin Endosc 46: 24, 2013.23422955"},{"key":"B36","series-title":"Onychomycosis: Diagnosis and Effective Management","first-page":"133","article-title":"\u201cPhotodynamic Therapy (PDT) in the Treatment of Onychomycosis,\u201d","author":"Sotiriou E","year":"2018","unstructured":"Sotiriou E, Ioannides D: \u201cPhotodynamic Therapy (PDT) in the Treatment of Onychomycosis,\u201d in Onychomycosis: Diagnosis and Effective Management, edited by D Rigopoulos, B Elewski, B Richer, p 133, John Wiley & Sons, Ltd, New York, 2018."},{"key":"B37","series-title":"Arch Dermatol","first-page":"19","article-title":"Successful treatment of toenail onychomycosis with photodynamic therapy","volume":"144","author":"Watanabe D","year":"2008","unstructured":"Watanabe D, Kawamura C, Masuda Y, : Successful treatment of toenail onychomycosis with photodynamic therapy. Arch Dermatol 144: 19, 2008.18209164"},{"key":"B38","series-title":"Pathogens","first-page":"263","article-title":"Photodynamic eradication of Trichophyton rubrum and Candida albicans","volume":"10","author":"Valkov A","year":"2021","unstructured":"Valkov A, Zinigrad M, Nisnevitch M: Photodynamic eradication of Trichophyton rubrum and Candida albicans. Pathogens 10: 263, 2021.33668866"},{"key":"B39","series-title":"Photodiagnosis Photodyn Ther","first-page":"102414","article-title":"Hypericin-P123-photodynamic therapy in an ex vivo model as an alternative treatment approach for onychomycosis caused by Fusarium spp","volume":"35","author":"Conrado PCV","year":"2021","unstructured":"Conrado PCV, Sakita KM, Arita GS, : Hypericin-P123-photodynamic therapy in an ex vivo model as an alternative treatment approach for onychomycosis caused by Fusarium spp. Photodiagnosis Photodyn Ther 35: 102414, 2021."},{"key":"B40","series-title":"Photodiagnosis Photodyn Ther","first-page":"228","article-title":"Photodynamic therapy for onychomycosis: a systematic review","volume":"15","author":"Bhatta AK","year":"2016","unstructured":"Bhatta AK, Keyal U, Wang XL: Photodynamic therapy for onychomycosis: a systematic review. Photodiagnosis Photodyn Ther 15: 228, 2016.27477248"},{"key":"B41","series-title":"J Photochem Photobiol B","first-page":"266","article-title":"Photodynamic therapy treatment of onychomycosis with aluminium-phthalocyanine chloride nanoemulsions: a proof of concept clinical trial","volume":"173","author":"Morgado LF","year":"2017","unstructured":"Morgado LF, Tr\u00e1volo ARF, Muehlmann LA, : Photodynamic therapy treatment of onychomycosis with aluminium-phthalocyanine chloride nanoemulsions: a proof of concept clinical trial. J Photochem Photobiol B 173: 266, 2017.28622558"},{"key":"B42","series-title":"Photodiagnosis Photodyn Ther","first-page":"101774","article-title":"Photodynamic therapy treatment of superficial fungal infections: a systematic review","volume":"31","author":"Shen JJ","year":"2020","unstructured":"Shen JJ, Jemec GBE, Arendrup MC, : Photodynamic therapy treatment of superficial fungal infections: a systematic review. Photodiagnosis Photodyn Ther 31: 101774, 2020.32339671"},{"key":"B43","series-title":"Dermatol Ther","first-page":"43","article-title":"Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis","volume":"27","author":"Figueiredo Souza LW","year":"2014","unstructured":"Figueiredo Souza LW, Souza SVT, Botelho ACC: Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis. Dermatol Ther 27: 43, 2014.24502311"},{"key":"B44","series-title":"J Eur Acad Dermatol Venereol","first-page":"347","article-title":"Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial","volume":"31","author":"Gilaberte Y","year":"2017","unstructured":"Gilaberte Y, Robres M, Fr\u00edas M, : Methyl aminolevulinate photodynamic therapy for onychomycosis: a multicentre, randomized, controlled clinical trial. J Eur Acad Dermatol Venereol 31: 347, 2017.27515478"},{"key":"B45","series-title":"Photodermatol Photoimmunol Photomed","first-page":"183","article-title":"Methylene blue-mediated photodynamic therapy may be superior to 5% amorolfine nail lacquer for non-dermatophyte onychomycosis","volume":"37","author":"Bowornsathitchai N","year":"2021","unstructured":"Bowornsathitchai N, Thammahong A, Shoosanglertwijit J, : Methylene blue-mediated photodynamic therapy may be superior to 5% amorolfine nail lacquer for non-dermatophyte onychomycosis. Photodermatol Photoimmunol Photomed 37: 183, 2021.33145834"},{"key":"B46","series-title":"Acta Derm Venereol","first-page":"467","article-title":"Laser-assisted photodynamic therapy or laser-assisted amorolfine lacquer delivery for treatment of toenail onychomycosis: an open-label comparative study","volume":"98","author":"Koren A","year":"2018","unstructured":"Koren A, Salameh F, Sprecher E, : Laser-assisted photodynamic therapy or laser-assisted amorolfine lacquer delivery for treatment of toenail onychomycosis: an open-label comparative study. Acta Derm Venereol 98: 467, 2018.29265166"},{"key":"B47","series-title":"J Dermatolog Treat","first-page":"542","article-title":"Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient\u2019s satisfaction in toenail onychomycosis treatment: an intra-patient comparative single-center study","volume":"33","author":"Abdallah M","year":"2022","unstructured":"Abdallah M, Abu-Ghail M, El-Sayed M, : Fractional CO2-assisted photodynamic therapy improves the clinical outcome and patient\u2019s satisfaction in toenail onychomycosis treatment: an intra-patient comparative single-center study. J Dermatolog Treat 33: 542, 2022."},{"key":"B48","series-title":"Dermatol Ther","first-page":"e14280","article-title":"Methylene blue vs methyl aminolevulinate photodynamic therapy in the treatment of mild-to-moderate toenail onychomycosis: short- and medium-term effects","volume":"33","author":"Alberdi E","year":"2020","unstructured":"Alberdi E, G\u00f3mez C: Methylene blue vs methyl aminolevulinate photodynamic therapy in the treatment of mild-to-moderate toenail onychomycosis: short- and medium-term effects. Dermatol Ther 33: e14280, 2020."},{"key":"B49","series-title":"Photodermatol Photoimmunol Photomed","first-page":"69","article-title":"Efficiency of methylene blue-mediated photodynamic therapy vs intense pulsed light in the treatment of onychomycosis in the toenails","volume":"35","author":"Alberdi E","year":"2019","unstructured":"Alberdi E, G\u00f3mez C: Efficiency of methylene blue-mediated photodynamic therapy vs intense pulsed light in the treatment of onychomycosis in the toenails. Photodermatol Photoimmunol Photomed 35: 69, 2019.30168611"},{"key":"B50","series-title":"Onychomycosis: Diagnosis and Effective Management","first-page":"141","article-title":"\u201cOnychomycosis and Iontophoresis,\u201d","author":"Shemer A","year":"2018","unstructured":"Shemer A: \u201cOnychomycosis and Iontophoresis,\u201d in Onychomycosis: Diagnosis and Effective Management, edited by D Rigopoulos, B Elewski, B Richer, p 141, John Wiley & Sons, Ltd, New York, 2018."},{"key":"B51","series-title":"Sci Pharm","first-page":"1","article-title":"Iontophoresis: a potential emergence of a transdermal drug delivery system","volume":"80","author":"Dhote V","year":"2012","unstructured":"Dhote V, Bhatnagar P, Mishra PK, : Iontophoresis: a potential emergence of a transdermal drug delivery system. Sci Pharm 80: 1, 2012.22396901"},{"key":"B52","series-title":"J Pharm Sci","first-page":"1788","article-title":"Trans-ungual iontophoretic delivery of terbinafine","volume":"98","author":"Nair AB","year":"2009","unstructured":"Nair AB, Vaka SRK, Sammeta SM, : Trans-ungual iontophoretic delivery of terbinafine. J Pharm Sci 98: 1788, 2009.18781625"},{"key":"B53","series-title":"J Pharm Sci","first-page":"4130","article-title":"Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis","volume":"98","author":"Nair AB","year":"2009","unstructured":"Nair AB, Kim HD, Chakraborty B, : Ungual and trans-ungual iontophoretic delivery of terbinafine for the treatment of onychomycosis. J Pharm Sci 98: 4130, 2009.19340887"},{"key":"B54","series-title":"Pharm Res","first-page":"3464","article-title":"Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy","volume":"29","author":"Dutet J","year":"2012","unstructured":"Dutet J, Delgado-Charro MB: Assessment of iontophoretic and passive ungual penetration by laser scanning confocal microscopy. Pharm Res 29: 3464, 2012.22869107"},{"key":"B55","series-title":"Pharmaceutics","first-page":"1692","article-title":"Constant voltage iontophoresis technique to deliver terbinafine via transungual delivery system: formulation optimization using Box-Behnken design and in vitro evaluation","volume":"13","author":"Nair AB","year":"2021","unstructured":"Nair AB, Al-Dhubiab BE, Shah J, : Constant voltage iontophoresis technique to deliver terbinafine via transungual delivery system: formulation optimization using Box-Behnken design and in vitro evaluation. Pharmaceutics 13: 1692, 2021.34683985"},{"key":"B56","series-title":"JAPMA","first-page":"565","article-title":"Low-voltage direct current as a fungicidal agent for treating onychomycosis","volume":"94","author":"Kalinowski DP","year":"2004","unstructured":"Kalinowski DP, Edsberg LE, Hewson RA, : Low-voltage direct current as a fungicidal agent for treating onychomycosis. JAPMA 94: 565, 2004."},{"key":"B57","series-title":"Br J Dermatol","first-page":"46","article-title":"Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study","volume":"162","author":"Amichai B","year":"2010","unstructured":"Amichai B, Nitzan B, Mosckovitz R, : Iontophoretic delivery of terbinafine in onychomycosis: a preliminary study. Br J Dermatol 162: 46, 2010.19785609"},{"key":"B58","series-title":"J Nov Physiother","first-page":"252","article-title":"Terbinafine hydrochloride 1% iontophoresis for the treatment of toenail onychomycosis: a randomized placebo controlled study","volume":"5","author":"Samhan AF","year":"2015","unstructured":"Samhan AF: Terbinafine hydrochloride 1% iontophoresis for the treatment of toenail onychomycosis: a randomized placebo controlled study. J Nov Physiother 5: 252, 2015."},{"key":"B59","series-title":"Int J Dermatol","first-page":"1171","article-title":"Cold atmospheric pressure (physical) plasma in dermatology: where are we today?","volume":"59","author":"Friedman PC","year":"2020","unstructured":"Friedman PC: Cold atmospheric pressure (physical) plasma in dermatology: where are we today? Int J Dermatol 59: 1171, 2020.32783244"},{"key":"B60","series-title":"Biomed Phys Eng Express","first-page":"025034","article-title":"Experimental investigation of sterilization efficacy of green nails symptom and gray nails using an argon-based round atmospheric-pressure plasma jet","volume":"5","author":"Wu MC","year":"2019","unstructured":"Wu MC, Liao CW, Lin ZH, : Experimental investigation of sterilization efficacy of green nails symptom and gray nails using an argon-based round atmospheric-pressure plasma jet. Biomed Phys Eng Express 5: 025034, 2019."},{"key":"B61","series-title":"IEEE Trans Plasma Sci","first-page":"815","article-title":"In vitro killing of clinical fungal strains by low-temperature atmospheric-pressure plasma jet","volume":"39","author":"Daeschlein G","year":"2011","unstructured":"Daeschlein G, Scholz S, von Woedtke T, : In vitro killing of clinical fungal strains by low-temperature atmospheric-pressure plasma jet. IEEE Trans Plasma Sci 39: 815, 2011."},{"key":"B62","series-title":"Future Microbiol","first-page":"1097","article-title":"Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment","volume":"8","author":"Heinlin J","year":"2013","unstructured":"Heinlin J, Maisch T, Zimmermann JL, : Contact-free inactivation of Trichophyton rubrum and Microsporum canis by cold atmospheric plasma treatment. Future Microbiol 8: 1097, 2013.24020738"},{"key":"B63","series-title":"Mycopathologia","first-page":"585","article-title":"Cold atmospheric pressure plasma jet reduces Trichophyton rubrum adherence and infection capacity","volume":"184","author":"Borges AC","year":"2019","unstructured":"Borges AC, Nishime TMC, de Moura Rovetta S, : Cold atmospheric pressure plasma jet reduces Trichophyton rubrum adherence and infection capacity. Mycopathologia 184: 585, 2019.31471824"},{"key":"B64","series-title":"Plasma Process Polym","first-page":"588","article-title":"Plasma treatment of onychomycosis","volume":"13","author":"Xiong Z","year":"2016","unstructured":"Xiong Z, Roe J, Grammer TC, : Plasma treatment of onychomycosis. Plasma Process Polym 13: 588, 2016."},{"key":"B65","series-title":"J Fungi (Basel)","first-page":"214","article-title":"Inactivation of dermatophytes causing onychomycosis and its therapy using non-thermal plasma","volume":"6","author":"Lux J","year":"2020","unstructured":"Lux J, Dobi\u00e1\u0161 R, Kuklov\u00e1 I, : Inactivation of dermatophytes causing onychomycosis and its therapy using non-thermal plasma. J Fungi (Basel) 6: 214, 2020.33050542"},{"key":"B66","series-title":"J Fungi (Basel)","first-page":"715","article-title":"Inactivation of dermatophytes causing onychomycosis using non-thermal plasma as a prerequisite for therapy","volume":"7","author":"Lokajov\u00e1 E","year":"2021","unstructured":"Lokajov\u00e1 E, Jul\u00e1k J, Khun J, : Inactivation of dermatophytes causing onychomycosis using non-thermal plasma as a prerequisite for therapy. J Fungi (Basel) 7: 715, 2021.34575753"},{"key":"B67","series-title":"Clin Exp Dermatol","first-page":"295","article-title":"Pilot study to evaluate a plasma device for the treatment of onychomycosis","volume":"42","author":"Lipner SR","year":"2017","unstructured":"Lipner SR, Friedman G, Scher RK: Pilot study to evaluate a plasma device for the treatment of onychomycosis. Clin Exp Dermatol 42: 295, 2017.28188648"},{"key":"B68","series-title":"Pharmaceutics","first-page":"29","article-title":"Transungual delivery of ciclopirox is increased 3\u20134-fold by mechanical fenestration of human nail plate in an in vitro model","volume":"11","author":"D\u00edaz DC","year":"2019","unstructured":"D\u00edaz DC, Losa Iglesias ME, Becerro de Bengoa Vallejo R, : Transungual delivery of ciclopirox is increased 3\u20134-fold by mechanical fenestration of human nail plate in an in vitro model. Pharmaceutics 11: 29, 2019."},{"key":"B69","series-title":"J Drugs Dermatol","first-page":"859","article-title":"The presence of an air gap between the nail plate and nail bed in onychomycosis patients: treatment implications for topical therapy","volume":"14","author":"Gupta AK","year":"2015","unstructured":"Gupta AK, Pillai R: The presence of an air gap between the nail plate and nail bed in onychomycosis patients: treatment implications for topical therapy. J Drugs Dermatol 14: 859, 2015.26267730"},{"key":"B70","series-title":"Med Mycol","first-page":"461","article-title":"Chemical and physical strategies in onychomycosis topical treatment: a review","volume":"55","author":"Angelo T","year":"2017","unstructured":"Angelo T, Borgheti-Cardoso LN, Gelfuso G, : Chemical and physical strategies in onychomycosis topical treatment: a review. Med Mycol 55: 461, 2017.27703019"},{"key":"B71","series-title":"Recent Pat Inflamm Allergy Drug Discov","first-page":"32","article-title":"Onychomycosis: an updated review","volume":"14","author":"Leung AKC","year":"2020","unstructured":"Leung AKC, Lam JM, Leong KF, : Onychomycosis: an updated review. Recent Pat Inflamm Allergy Drug Discov 14: 32, 2020.31738146"},{"key":"B72","series-title":"Am J Emerg Med","first-page":"875","article-title":"Controlled nail trephination for subungual hematoma","volume":"24","author":"Salter SA","year":"2006","unstructured":"Salter SA, Ciocon DH, Gowrishankar TR, : Controlled nail trephination for subungual hematoma. Am J Emerg Med 24: 875, 2006.17098113"},{"key":"B73","series-title":"Clin Dermatol","first-page":"555","article-title":"Improved efficacy in onychomycosis therapy","volume":"5","author":"Gupta AK","year":"2013","unstructured":"Gupta AK, Paquet M: Improved efficacy in onychomycosis therapy. Clin Dermatol 5: 555, 2013."},{"key":"B74","series-title":"J Drugs Dermatol","first-page":"974","article-title":"Rapid treatment of subungual onychomycosis using controlled micro nail penetration and terbinafine solution","volume":"15","author":"Bristow I","year":"2016","unstructured":"Bristow I, Baran R, Score M: Rapid treatment of subungual onychomycosis using controlled micro nail penetration and terbinafine solution. J Drugs Dermatol 15: 974, 2016.27537998"},{"key":"B75","series-title":"J Control Release","first-page":"72","article-title":"Precise laser poration to control drug delivery into and through human nail","volume":"268","author":"Vanstone S","year":"2017","unstructured":"Vanstone S, Cordery SF, Stone JM, : Precise laser poration to control drug delivery into and through human nail. J Control Release 268: 72, 2017.29051061"},{"key":"B76","series-title":"Mycopathologia","first-page":"127","article-title":"New antifungal agents and new formulations against dermatophytes","volume":"182","author":"Gupta AK","year":"2017","unstructured":"Gupta AK, Foley KA, Versteeg SG: New antifungal agents and new formulations against dermatophytes. Mycopathologia 182: 127, 2017.27502503"},{"key":"B77","series-title":"Int J Pharm","first-page":"237","article-title":"Enhancement of tioconazole ungual delivery: combining nanocapsule formulation and nail poration approaches","volume":"535","author":"Flores FC","year":"2018","unstructured":"Flores FC, Chiu WS, Beck RCR, : Enhancement of tioconazole ungual delivery: combining nanocapsule formulation and nail poration approaches. Int J Pharm 535: 237, 2018.29126904"},{"key":"B78","series-title":"J Control Release","first-page":"98","article-title":"Drug delivery into microneedle-porated nails from nanoparticle reservoirs","volume":"220","author":"Chiu WS","year":"2015","unstructured":"Chiu WS, Belsey NA, Garrett NL, : Drug delivery into microneedle-porated nails from nanoparticle reservoirs. J Control Release 220: 98, 2015.26478016"},{"key":"B79","series-title":"J Dermatol Treat","first-page":"480","article-title":"An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis","volume":"27","author":"Shemer A","year":"2016","unstructured":"Shemer A, Gupta AK, Amichai B, : An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis. J Dermatol Treat 27: 480, 2016."},{"key":"B80","series-title":"J Cosmet Dermatol","first-page":"2333","article-title":"Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment","volume":"19","author":"Bunyaratavej S","year":"2020","unstructured":"Bunyaratavej S, Wanitphakdeedecha R, Ungaksornpairote C, : Randomized controlled trial comparing long-pulsed 1064-Nm neodymium: yttrium-aluminum-garnet laser alone, topical amorolfine nail lacquer alone, and a combination for nondermatophyte onychomycosis treatment. J Cosmet Dermatol 19: 2333, 2020."},{"key":"B81","series-title":"J Eur Acad Dermatol Venereol","first-page":"2143","article-title":"Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1)","volume":"33","author":"Nijenhuis-Rosien L","year":"2019","unstructured":"Nijenhuis-Rosien L, Kleefstra N, van Dijk PR, : Laser therapy for onychomycosis in patients with diabetes at risk for foot ulcers: a randomized, quadruple-blind, sham-controlled trial (LASER-1). J Eur Acad Dermatol Venereol 33: 2143, 2019.30920059"},{"key":"B82","series-title":"J Cutan Med Surg","first-page":"507","article-title":"A randomized, double-blind, controlled trial evaluating the efficacy of Nd:YAG 1064 nm short-pulse laser compared with placebo in the treatment of toenail onychomycosis","volume":"23","author":"Sabbah L","year":"2019","unstructured":"Sabbah L, Gagnon C, Bernier FE, : A randomized, double-blind, controlled trial evaluating the efficacy of Nd:YAG 1064 nm short-pulse laser compared with placebo in the treatment of toenail onychomycosis. J Cutan Med Surg 23: 507, 2019.31296045"},{"key":"B83","series-title":"J Cutan Med Surg","first-page":"301","article-title":"Laser therapy for onychomycosis","volume":"17","author":"Gupta AK","year":"2013","unstructured":"Gupta AK, Simpson FC: Laser therapy for onychomycosis. J Cutan Med Surg 17: 301, 2013.24067848"},{"key":"B84","series-title":"J Cutan Med Surg","first-page":"114","article-title":"Lasers for onychomycosis","volume":"21","author":"Gupta AK","year":"2017","unstructured":"Gupta AK, Foley KA, Versteeg SG: Lasers for onychomycosis. J Cutan Med Surg 21: 114, 2017.27815496"},{"key":"B85","series-title":"Science","first-page":"524","article-title":"Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation","volume":"220","author":"Allison R","year":"1983","unstructured":"Allison R, Parrish J: Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 220: 524, 1983."},{"key":"B86","series-title":"Int J Curr Microbiol Appl Sci","first-page":"838","article-title":"The effect of mobile waves on the growth of pathogenic fungi","volume":"4","author":"Ahmed LT","year":"2015","unstructured":"Ahmed LT, Majeed AD, Salhi SA: The effect of mobile waves on the growth of pathogenic fungi. Int J Curr Microbiol Appl Sci 4: 838, 2015."},{"key":"B87","series-title":"Mycoses","first-page":"209","article-title":"The effect of microwave irradiation on the vitality of various dermatophytes","volume":"57","author":"Budihardja D","year":"2014","unstructured":"Budihardja D, Mayser P: The effect of microwave irradiation on the vitality of various dermatophytes. Mycoses 57: 209, 2014.24612041"},{"key":"B88","article-title":"Low-frequency ultrasound to enhance topical drug delivery to the nail","author":"Torkar A","unstructured":"Torkar A, Kristl J, Murdan S: Low-frequency ultrasound to enhance topical drug delivery to the nail. Paper presented at: AAPS Annual Meeting and Exposition, San Diego, California, November 11-15, 2007."},{"key":"B89","series-title":"J Ultrasound Med","first-page":"1723","article-title":"Ultrasound-mediated nail drug delivery system","volume":"30","author":"Abadi D","year":"2011","unstructured":"Abadi D, Zderic V: Ultrasound-mediated nail drug delivery system. J Ultrasound Med 30: 1723, 2011.22124008"},{"key":"B90","series-title":"J Ultrasound Med","first-page":"1743","article-title":"Ultrasound-enhanced drug delivery for treatment of onychomycosis","volume":"37","author":"Kline-Schoder A","year":"2018","unstructured":"Kline-Schoder A, Le Z, Zderic V: Ultrasound-enhanced drug delivery for treatment of onychomycosis. J Ultrasound Med 37: 1743, 2018.29288596"},{"key":"B91","series-title":"Annu Int Conf IEEE Eng Med Biol Soc","first-page":"5717","article-title":"Ultrasound-enhanced ciclopirox delivery for treatment of onychomycosis","volume":"2018","author":"Kline-Schoder A","year":"2018","unstructured":"Kline-Schoder A, Le Z, Zderic V: Ultrasound-enhanced ciclopirox delivery for treatment of onychomycosis. Annu Int Conf IEEE Eng Med Biol Soc 2018: 5717, 2018.30441634"},{"key":"B92","series-title":"JAPMA","article-title":"Optimization of ultrasound-mediated drug delivery for treatment of onychomycosis","author":"Kline-Schoder A","unstructured":"Kline-Schoder A, Le Z, Sweeney L, : Optimization of ultrasound-mediated drug delivery for treatment of onychomycosis. JAPMA Published online ahead of print October 24, 2019; https:\/\/doi.org\/10.7547\/18-084."},{"key":"B93","series-title":"J Dermatol Treat","first-page":"498","article-title":"How do we measure efficacy of therapy in onychomycosis: patient, physician, and regulatory perspectives","volume":"27","author":"Gupta AK","year":"2016","unstructured":"Gupta AK, Studholme C: How do we measure efficacy of therapy in onychomycosis: patient, physician, and regulatory perspectives. J Dermatol Treat 27: 498, 2016."}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/113\/1\/21-240.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/113\/1\/21-240.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/113\/1\/21-240.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:19:05Z","timestamp":1783505945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/113\/1\/21240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":93,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.7547\/21-240","relation":{},"ISSN":["8750-7315"],"issn-type":[{"value":"8750-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}